Pancreatic beta-cell survival pathways

Pancreatic beta-cell survival pathways are a collection of intracellular signaling networks essential for maintaining the mass and functional integrity of insulin-producing cells in the pancreatic islets. Central to these pathways are the GLP-1 receptor (GLP-1R) and the PI3K/Akt/mTOR signaling axis, which integrate nutritional and hormonal signals to promote cell proliferation and suppress programmed cell death (apoptosis) [3, 5, 8]. These pathways regulate the expression of anti-apoptotic proteins like Bcl-2 and crucial transcription factors such as Pancreas/duodenum homeobox protein 1 (PDX-1), which are vital for beta-cell identity and insulin biosynthesis [5, 10]. In diabetes, chronic exposure to high glucose and fatty acids (glucolipotoxicity), along with inflammatory cytokines, disrupts these survival signals, leading to beta-cell failure and death [4, 6]. Pharmacological interventions, including GLP-1 receptor agonists and DPP-4 inhibitors, leverage these pathways to enhance beta-cell resilience and potentially stimulate regeneration [1, 10]. Ongoing research into novel targets like DYRK1A and GPR40 aims to further expand the therapeutic toolkit for preserving beta-cell function in metabolic diseases [1, 9].

Other names

Beta-cell survival signalingPancreatic beta-cell regenerative pathwaysBeta-cell preservation pathwaysIslet cell survival pathways

Activation of GLP-1 receptor signaling, inhibition of DPP-4 to increase incretin levels, activation of GPR40, inhibition of DYRK1A to promote proliferation, and modulation of PI3K/Akt and Bcl-2 pathways to prevent apoptosis.